Immune Reactions Towards Biopharmaceuticals – a General, Mechanistic Overview

  • Camilla Foged
  • Anne Sundblad
Part of the Biotechnology: Pharmaceutical Aspects book series (PHARMASP, volume VIII)


Dendritic Cell Major Histocompatibility Complex Major Histocompatibility Complex Class Therapeutic Protein Major Histocompatibility Complex Molecule 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ackerman, A.L. and Cresswell, P. 2004. Cellular mechanisms governing cross-presentation of exogenous antigens. Nat. Immunol. 5:678–684PubMedGoogle Scholar
  2. Aderem, A. and Underhill, D.M. 1999. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17:593–623PubMedGoogle Scholar
  3. Akira, S. and Takeda, K. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499–511PubMedGoogle Scholar
  4. Albert, M.L., Pearce, S.F., Francisco, L.M., Sauter, B., Roy, P., Silverstein, R.L., and Bhardwaj, N. 1998. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188:1359–1368PubMedGoogle Scholar
  5. Amyere, M., Mettlen, M., Van, D., Platek, A., Payrastre, B., Veithen, A., and Courtoy, P.J. 2002. Origin, originality, functions, subversions and molecular signalling of macropinocytosis. Int. J. Med. Microbiol. 291:487–494PubMedGoogle Scholar
  6. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.J., Pulendran, B., and Palucka, K. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767–811PubMedGoogle Scholar
  7. Banchereau, J. and Steinman, R.M. 1998. Dendritic cells and the control of immunity. Nature 392:245–252PubMedGoogle Scholar
  8. Bouvier, M. 2003. Accessory proteins and the assembly of human class I MHC molecules: a molecular and structural perspective. Mol. Immunol. 39:697–706PubMedGoogle Scholar
  9. Cannons, J.L. and Schwartzberg, P.L. 2004. Fine-tuning lymphocyte regulation: what’s new with tyrosine kinases and phosphatases? Curr. Opin. Immunol. 16:296–303PubMedGoogle Scholar
  10. Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I., and Banchereau, J. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263–1272PubMedGoogle Scholar
  11. Cella, M., Engering, A., Pinet, V., Pieters, J., and Lanzavecchia, A. 1997a. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388:782–787Google Scholar
  12. Cella, M., Salio, M., Sakakibara, Y., Langen, H., Julkunen, I., and Lanzavecchia, A. 1999. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189:821–829PubMedGoogle Scholar
  13. Cella, M., Sallusto, F., and Lanzavecchia, A. 1997b. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9:10–16Google Scholar
  14. Chamaillard, M., Hashimoto, M., Horie, Y., Masumoto, J., Qiu, S., Saab, L., Ogura, Y., Kawasaki, A., Fukase, K., Kusumoto, S., Valvano, M.A., Foster, S.J., Mak, T.W., Nunez, G., and Inohara, N. 2003. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 4:702–707PubMedGoogle Scholar
  15. Chan, E.Y. and MacLennan, I.C. 1993. Only a small proportion of splenic B cells in adults are short-lived virgin cells. Eur. J. Immunol. 23:357–363PubMedGoogle Scholar
  16. Cooke, M.P., Heath, A.W., Shokat, K.M., Zeng, Y., Finkelman, F.D., Linsley, P.S., Howard, M., and Goodnow, C.C. 1994. Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J. Exp. Med. 179:425–438PubMedGoogle Scholar
  17. Cornall, R.J., Goodnow, C.C., and Cyster, J.G. 1995. The regulation of self-reactive B cells. Curr. Opin. Immunol. 7:804–811PubMedGoogle Scholar
  18. Coutinho, A., Gronowicz, E., and Moller, G. 1975. Mechanism of B-Cell Activation and Paralysis by Thymus-Independent Antigens – Additive Effects Between Nnp-Lps and Lps in Specific Response to Hapten. Scand. J. Immunol. 4:89–94PubMedGoogle Scholar
  19. Cresswell, P. 1996. Invariant chain structure and MHC class II function. Cell 84:505–507PubMedGoogle Scholar
  20. Cresswell, P., Bangia, N., Dick, T., and Diedrich, G. 1999. The nature of the MHC class I peptide loading complex. Immunol. Rev. 172:21–28PubMedGoogle Scholar
  21. De Boer, R.J. and Perelson, A.S. 1993. How diverse should the immune system be? Proc. Biol. Sci. 252:171–175Google Scholar
  22. Delamarre, L., Pack, M., Chang, H., Mellman, I., and Trombetta, E.S. 2005. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 307:1630–1634PubMedGoogle Scholar
  23. Dustin, M.L. and Cooper, J.A. 2000. The immunological synapse and the actin cytoskeleton: molecular hardware for T cell signaling. Nat. Immunol. 1:23–29PubMedGoogle Scholar
  24. Erikson, J., Radic, M.Z., Camper, S.A., Hardy, R.R., Carmack, C., and Weigert, M. 1991. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature 349:331–334PubMedGoogle Scholar
  25. Fanger, N.A., Wardwell, K., Shen, L., Tedder, T.F., and Guyre, P.M. 1996. Type I (CD64) and type II (CD32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells. J. Immunol. 157:541–548PubMedGoogle Scholar
  26. Fisher, G.H., Rosenberg, F.J., Straus, S.E., Dale, J.K., Middleton, L.A., Lin, A.Y., Strober, W., Lenardo, M.J., and Puck, J.M. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935–946PubMedGoogle Scholar
  27. Fluckiger, A.C., Li, Z.M., Kato, R.M., Wahl, M.I., Ochs, H.D., Longnecker, R., Kinet, J.P., Witte, O.N., Scharenberg, A.M., and Rawlings, D.J. 1998. Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation. EMBO J. 17:1973–1985PubMedGoogle Scholar
  28. Gallucci, S., Lolkema, M., and Matzinger, P. 1999. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5:1249–1255PubMedGoogle Scholar
  29. Germain, R.N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287–299PubMedGoogle Scholar
  30. Girardin, S.E., Boneca, I.G., Carneiro, L.A.M., Antignac, A., Jehanno, M., Viala, J., Tedin, K., Taha, M.K., Labigne, A., Zahringer, U., Coyle, A.J., Bertin, J., Sansonetti, P.J., and Philpott, D.J. 2003a. Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science 300:1584–1587Google Scholar
  31. Girardin, S.E., Boneca, I.G., Viala, J., Chamaillard, M., Labigne, A., Thomas, G., Philpott, D.J., and Sansonetti, P.J. 2003b. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278:8869–8872Google Scholar
  32. Girardin, S.E., Tournebize, R., Mavris, M., Page, A.L., Li, X., Stark, G.R., Bertin, J., DiStefano, P.S., Yaniv, M., Sansonetti, P.J., and Philpott, D.J. 2001. CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep. 2:736–742PubMedGoogle Scholar
  33. Gotter, J., Brors, B., Hergenhahn, M., and Kyewski, B. 2004. Medullary epithelial cells of the human thymus express a highly diverse selection of tissue-specific genes colocalized in chromosomal clusters. J. Exp. Med. 199:155–166PubMedGoogle Scholar
  34. Gowans, J.L. 1996. The lymphocyte–a disgraceful gap in medical knowledge. Immunol. Today 17:288–291PubMedGoogle Scholar
  35. Guermonprez, P., Valladeau, J., Zitvogel, L., Thery, C., and Amigorena, S. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20:621–667PubMedGoogle Scholar
  36. Hart, D.N. 1997. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90:3245–3287PubMedGoogle Scholar
  37. Hartley, S.B., Cooke, M.P., Fulcher, D.A., Harris, A.W., Cory, S., Basten, A., and Goodnow, C.C. 1993. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 72:325–335PubMedGoogle Scholar
  38. Hartley, S.B., Crosbie, J., Brink, R., Kantor, A.B., Basten, A., and Goodnow, C.C. 1991. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 353:765–769PubMedGoogle Scholar
  39. Healy, J.I. and Goodnow, C.C. 1998. Positive versus negative signaling by lymphocyte antigen receptors. Annu. Rev. Immunol. 16:645–670PubMedGoogle Scholar
  40. Hippen, K.L., Schram, B.R., Tze, L.E., Pape, K.A., Jenkins, M.K., and Behrens, T.W. 2005. In vivo assessment of the relative contributions of deletion, anergy, and editing to B cell self-tolerance. J. Immunol. 175:909–916PubMedGoogle Scholar
  41. Inaba, K., Turley, S., Yamaide, F., Iyoda, T., Mahnke, K., Inaba, M., Pack, M., Subklewe, M., Sauter, B., Sheff, D., Albert, M., Bhardwaj, N., Mellman, I., and Steinman, R.M. 1998. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 188:2163–2173PubMedGoogle Scholar
  42. Inohara, N., Ogura, Y., Fontalba, A., Gutierrez, O., Pons, F., Crespo, J., Fukase, K., Inamura, S., Kusumoto, S., Hashimoto, M., Foster, S.J., Moran, A.P., Fernandez-Luna, J.L., and Nunez, G. 2003. Host recognition of bacterial muramyl dipeptide mediated through NOD2. J. Biol. Chem. 278:5509–5512PubMedGoogle Scholar
  43. Iyoda, T., Shimoyama, S., Liu, K., Omatsu, Y., Akiyama, Y., Maeda, Y., Takahara, K., Steinman, R.M., and Inaba, K. 2002. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195:1289–1302PubMedGoogle Scholar
  44. Jacque, J. M., Triques, K., and Stevenson, M. 2002. Modulation of HIV-1 replication by RNA interference. Nature 418:435–438PubMedGoogle Scholar
  45. Janeway, C.A. Jr. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54 Pt 1:1–13PubMedGoogle Scholar
  46. Janeway, C.A. Jr. and Bottomly, K. 1994. Signals and signs for lymphocyte responses. Cell 76:275–285PubMedGoogle Scholar
  47. Jenkins, M.K. and Schwartz, R.H. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T-cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302–319PubMedGoogle Scholar
  48. Jiang, W., Swiggard, W.J., Heufler, C., Peng, M., Mirza, A., Steinman, R.M., and Nussenzweig, M.C. 1995. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 375:151–155PubMedGoogle Scholar
  49. Kirchner, H., Korfer, A., Palmer, P.A., Evers, P., De Riese, W., Knuver-Hopf, J., Hadam, M., Goldman, U., Franks, C.R., and Poliwoda, H. 1990. Subcutaneous interleukin-2 and interferon-alpha 2b in patients with metastatic renal cell cancer: the German outpatient experience. Mol. Biother. 2:145–154PubMedGoogle Scholar
  50. Kleijmeer, M.J., Ossevoort, M.A., van Veen, C.J., van Hellemond, J.J., Neefjes, J.J., Kast, W.M., Melief, C.J., and Geuze, H.J. 1995. MHC class II compartments and the kinetics of antigen presentation in activated mouse spleen dendritic cells. J. Immunol. 154:5715–5724PubMedGoogle Scholar
  51. Kovacsovics-Bankowski, M., Clark, K., Benacerraf, B., and Rock, K.L. 1993. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. USA 90:4942–4946PubMedGoogle Scholar
  52. Kovacsovics-Bankowski, M. and Rock, K.L. 1995. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267:243–246PubMedGoogle Scholar
  53. Kropshofer, H., Hammerling, G.J., and Vogt, A.B. 1999. The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules. Immunol. Rev. 172:267–278PubMedGoogle Scholar
  54. Kunisawa, J. and Shastri, N. 2003. The group II chaperonin TRiC protects proteolytic intermediates from degradation in the MHC class I antigen processing pathway. Mol. Cell 12:565–576PubMedGoogle Scholar
  55. Kyewski, B. and Klein, L. 2006. A central role for central tolerance. Annu. Rev. Immunol. 24:571–606PubMedGoogle Scholar
  56. Lang, J., Jackson, M., Teyton, L., Brunmark, A., Kane, K., and Nemazee, D. 1996. B cells are exquisitely sensitive to central tolerance and receptor editing induced by ultralow affinity, membrane-bound antigen. J. Exp. Med. 184:1685–1697PubMedGoogle Scholar
  57. Lanzavecchia, A. 1987. Antigen uptake and accumulation in antigen-specific B-cells. Immunol. Rev. 99:39–51PubMedGoogle Scholar
  58. Lanzavecchia, A. 1990. Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu. Rev. Immunol. 8:773–793PubMedGoogle Scholar
  59. Leibson, P.J. 2004. The regulation of lymphocyte activation by inhibitory receptors. Curr. Opin. Immunol. 16:328–336PubMedGoogle Scholar
  60. Lund, F.E., Garvy, B.A., Randall, T.D., and Harris, D.P. 2005. Regulatory roles for cytokine-producing B cells in infection and autoimmune disease. Curr. Dir. Autoimmun. 8:25–54PubMedGoogle Scholar
  61. MacLennan, I.C. and Gray, D. 1986. Antigen-driven selection of virgin and memory B cells. Immunol. Rev. 91:61–85PubMedGoogle Scholar
  62. Mariathasan, S. and Monack, D.M. 2007. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat. Rev. Immunol. 7:31–40PubMedGoogle Scholar
  63. Marques, J.T. and Williams, B.R.G. 2005. Activation of the mammalian immune system by siRNAs. Nat. Biotechnol. 23:1399–1405PubMedGoogle Scholar
  64. Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991–1045PubMedGoogle Scholar
  65. Matzinger, P. 2002. The danger model: a renewed sense of self. Science 296:301–305PubMedGoogle Scholar
  66. Medzhitov, R. and Janeway, C.A. Jr. 2002. Decoding the patterns of self and nonself by the innate immune system. Science 296:298–300PubMedGoogle Scholar
  67. Medzhitov, R., Preston-Hurlburt, P., and Janeway, C.A. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394–397PubMedGoogle Scholar
  68. Melchers, F. and Rolink, A.R. 2006. B cell tolerance – How to make it and how to break it. Curr. Concepts Autoimmun. Chron. Inflam. 305:1–23Google Scholar
  69. Mellman, I. and Steinman, R.M. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106:255–258PubMedGoogle Scholar
  70. Mempel, T.R., Henrickson, S.E., and von Andrian, U.H. 2004. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427:154–159PubMedGoogle Scholar
  71. Miller, J.F. and Basten, A. 1996. Mechanisms of tolerance to self. Curr. Opin. Immunol. 8:815–821PubMedGoogle Scholar
  72. Mosmann, T.R. and Coffman, R.L. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145–173PubMedGoogle Scholar
  73. Nemazee, D. 1996. Antigen receptor ‘capacity’ and the sensitivity of self-tolerance. Immunol. Today 17:25–29PubMedGoogle Scholar
  74. Nemazee, D. and Hogquist, K.A. 2003. Antigen receptor selection by editing or downregulation of V(D)J recombination. Curr. Opin. Immunol. 15:182–189PubMedGoogle Scholar
  75. Nemazee, D.A. and Burki, K. 1989. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337:562–566PubMedGoogle Scholar
  76. Norbury, C.C., Chambers, B.J., Prescott, A.R., Ljunggren, H.G., and Watts, C. 1997. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur. J. Immunol. 27:280–288PubMedGoogle Scholar
  77. Nouri-Shirazi, M., Banchereau, J., Fay, J., and Palucka, K. 2000. Dendritic cell based tumor vaccines. Immunol. Lett. 74:5–10PubMedGoogle Scholar
  78. Pancer, Z. and Cooper, M.D. 2006. The evolution of adaptive immunity. Annu. Rev. Immunol. 24:497–518PubMedGoogle Scholar
  79. Parker, D.C. 1993. T-Cell - Dependent B-Cell Activation. Annu. Rev. Immunol. 11:331–360PubMedGoogle Scholar
  80. Perini, P., Facchinetti, A., Bulian, P., Massaro, A.R., De Pascalis, D., Bertolotto, A., Biasi, G., and Gallo, P. 2001. Interferon-beta (IFN-beta) antibodies in interferon-beta 1a-and interferon-beta 1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo. Eur. Cytokine Network 12:56–61Google Scholar
  81. Pfeifer, J.D., Wick, M.J., Roberts, R.L., Findlay, K., Normark, S.J., and Harding, C.V. 1993. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361:359–362PubMedGoogle Scholar
  82. Philpott, D.J. and Girardin, S.E. 2004. The role of Toll-like receptors and Nod proteins in bacterial infection. Mol. Immunol. 41:1099–1108PubMedGoogle Scholar
  83. Poltorak, A., He, X., Smirnova, I., Liu, M.Y., Van Huffel, C., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., Freudenberg, M., Ricciardi-Castagnoli, P., Layton, B., and Beutler, B. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085–2088PubMedGoogle Scholar
  84. Probst, H.C., McCoy, K., Okazaki, T., Honjo, T., and Van Den, B.M. 2005. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat. Immunol. 6:280–286Google Scholar
  85. Randolph, G.J. 2001. Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators. Semin. Immunol. 13:267–274Google Scholar
  86. Rathmell, J.C., Cooke, M.P., Ho, W.Y., Grein, J., Townsend, S.E., Davis, M.M., and Goodnow, C.C. 1995. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 376:181–184PubMedGoogle Scholar
  87. Rathmell, J.C., Fournier, S., Weintraub, B.C., Allison, J.P., and Goodnow, C.C. 1998. Repression of B7.2 on self-reactive B cells is essential to prevent proliferation and allow Fas-mediated deletion by CD4(+) T cells. J. Exp. Med. 188:651–659PubMedGoogle Scholar
  88. Rathmell, J.C., Townsend, S.E., Xu, J.C., Flavell, R.A., and Goodnow, C.C. 1996. Expansion or elimination of B cells in vivo: dual roles for. Cell 87:319–329PubMedGoogle Scholar
  89. Raychaudhuri, S. and Rock, K.L. 1998. Fully mobilizing host defense: building better vaccines. Nat. Biotechnol. 16:1025–1031PubMedGoogle Scholar
  90. Regnault, A., Lankar, D., Lacabanne, V., Rodriguez, A., Thery, C., Rescigno, M., Saito, T., Verbeek, S., Bonnerot, C., Ricciardi-Castagnoli, P., and Amigorena, S. 1999. Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. 189:371–380PubMedGoogle Scholar
  91. Reis e Sousa, C., Stahl, P.D., and Austyn, J.M. 1993. Phagocytosis of antigens by Langerhans cells in vitro. J. Exp. Med. 178:509–519Google Scholar
  92. Rescigno, M., Citterio, S., Thery, C., Rittig, M., Medaglini, D., Pozzi, G., Amigorena, S., and Ricciardi-Castagnoli, P. 1998. Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells. Proc. Natl. Acad. Sci. USA 95:5229–5234PubMedGoogle Scholar
  93. Reth, M. 1995. The B-cell antigen receptor complex and co-receptors. Immunol. Today 16:310–313PubMedGoogle Scholar
  94. Rodriguez, A., Regnault, A., Kleijmeer, M., Ricciardi-Castagnoli, P., and Amigorena, S. 1999. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat. Cell. Biol. 1:362–368PubMedGoogle Scholar
  95. Rosenberg, A.S. 2006. Effects of protein aggregates: an immunologic perspective. AAPS J 8:E501–E507PubMedGoogle Scholar
  96. Ross, C., Clemmesen, K.M., Svenson, M., Sorensen, P.S., Koch-Henriksen, N., Skovgaard, G.L., and Bendtzen, K. 2000. Immunogenicity of interferon-beta in multiple sclerosis patients: Influence of preparation, dosage, dose frequency, and route of administration. Ann. Neurol. 48:706–712PubMedGoogle Scholar
  97. Rubartelli, A., Poggi, A., and Zocchi, M.R. 1997. The selective engulfment of apoptotic bodies by dendritic cells is mediated by the alpha(v)beta3 integrin and requires intracellular and extracellular calcium. Eur. J. Immunol. 27:1893–1900PubMedGoogle Scholar
  98. Ryff, J.C. 1997. Clinical investigation of the immunogenicity of interferon-alpha 2a. J. Interferon Cytokine Res. 17 Suppl 1:S29–S33PubMedGoogle Scholar
  99. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., and Toda, M. 1995. Immunological self-tolerance maintained by activated T-cells expressing Il-2 receptor alpha-chains (Cd25) – breakdown of a single mechanism of self-tolerance causes various autoimmune-diseases. J. Immunol. 155:1151–1164PubMedGoogle Scholar
  100. Sallusto, F., Cella, M., Danieli, C., and Lanzavecchia, A. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182:389–400PubMedGoogle Scholar
  101. Sallusto, F. and Lanzavecchia, A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109–1118PubMedGoogle Scholar
  102. Sansonetti, P.J. 2006. The innate signaling of dangers and the dangers of innate signaling. Nat. Immunol. 7:1237–1242PubMedGoogle Scholar
  103. Sauter, B., Albert, M.L., Francisco, L., Larsson, M., Somersan, S., and Bhardwaj, N. 2000. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191:423–434PubMedGoogle Scholar
  104. Savill, J., Dransfield, I., Gregory, C., and Haslett, C. 2002. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2:965–975PubMedGoogle Scholar
  105. Schellekens, H. 2002. Immunogenicity of therapeutic proteins: clinical implications and future prospects. Clin. Ther. 24:1720–1740PubMedGoogle Scholar
  106. Schellekens, H. 2005. Factors influencing the immunogenicity of therapeutic proteins. Nephrol. Dial. Transpl. 20:3–9Google Scholar
  107. Schwartz, R.H. 2003. T cell anergy. Annu. Rev. Immunol. 21:305–334PubMedGoogle Scholar
  108. Shastri, N., Schwab, S., and Serwold, T. 2002. Producing nature’s gene-chips: The generation of peptides for display by MHC class I molecules. Annu. Rev. Immunol. 20:463–493PubMedGoogle Scholar
  109. Singh, N.J. and Schwartz, R.H. 2006. Primer: mechanisms of immunologic tolerance. Nat. Clin. Pract. Rheumatol. 2:44–52PubMedGoogle Scholar
  110. Singh-Jasuja, H., Scherer, H.U., Hilf, N., Arnold-Schild, D., Rammensee, H.G., Toes, R.E., and Schild, H. 2000. The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur. J. Immunol. 30:2211–2215PubMedGoogle Scholar
  111. Slepnev, V.I. and De Camilli, P. 2000. Accessory factors in clathrin-dependent synaptic vesicle endocytosis. Nat. Rev. Neurosci. 1:161–172PubMedGoogle Scholar
  112. Smits, H.H., de Jong, E.C., Wierenga, E.A., and Kapsenberg, M.L. 2005. Different faces of regulatory DCs in homeostasis and immunity. Trends Immunol. 26:123–129PubMedGoogle Scholar
  113. Squier, M.K. and Cohen, J.J. 1994. Cell-mediated cytotoxic mechanisms. Curr. Opin. Immunol. 6:447–452PubMedGoogle Scholar
  114. Steinman, R.M., Inaba, K., Turley, S., Pierre, P., and Mellman, I. 1999. Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. Hum. Immunol. 60:562–567PubMedGoogle Scholar
  115. Steinman, R.M. and Swanson, J. 1995. The endocytic activity of dendritic cells. J. Exp. Med. 182:283–288PubMedGoogle Scholar
  116. Steinman, R.M., Turley, S., Mellman, I., and Inaba, K. 2000. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191:411–416PubMedGoogle Scholar
  117. Surh, C.D. and Sprent, J. 1994. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372:100–103PubMedGoogle Scholar
  118. Takeda, K. and Akira, S. 2005. Toll-like receptors in innate immunity. Int. Immunol. 17:1–14PubMedGoogle Scholar
  119. Tang, A., Amagai, M., Granger, L.G., Stanley, J.R., and Udey, M.C. 1993. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E- cadherin. Nature 361:82–85PubMedGoogle Scholar
  120. Taniguchi, M., Harada, M., Kojo, S., Nakayama, T., and Wakao, H. 2003. The regulatory role of V alpha 14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21:483–513PubMedGoogle Scholar
  121. Tiegs, S.L., Russell, D.M., and Nemazee, D. 1993. Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 177:1009–1020PubMedGoogle Scholar
  122. Trombetta, E.S. and Mellman, I. 2005. Cell biology of antigen processing in vitro and in vivo. Annu. Rev. Immunol. 23:975–1028PubMedGoogle Scholar
  123. Turley, S.J., Inaba, K., Garrett, W.S., Ebersold, M., Unternaehrer, J., Steinman, R.M., and Mellman, I. 2000. Transport of peptide-MHC class II complexes in developing dendritic cells. Science 288:522–527PubMedGoogle Scholar
  124. Villadangos, J.A., Bryant, R.A., Deussing, J., Driessen, C., Lennon-Dumenil, A.M., Riese, R.J., Roth, W., Saftig, P., Shi, G.P., Chapman, H.A., Peters, C., and Ploegh, H.L. 1999. Proteases involved in MHC class II antigen presentation. Immunol. Rev. 172:109–120PubMedGoogle Scholar
  125. Vivier, E. and Malissen, B. 2005. Innate and adaptive immunity: specificities and signaling hierarchies revisited. Nat. Rev. Immunol. 6:17–21Google Scholar
  126. von Andrian, U.H. and Mempel, T.R. 2003. Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 3:867–878Google Scholar
  127. Vos, Q., Lees, A., Wu, Z.Q., Snapper, C.M., and Mond, J.J. 2000. B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol. Rev. 176:154–170PubMedGoogle Scholar
  128. Wardemann, H., Yurasov, S., Schaefer, A., Young, J.W., Meffre, E., and Nussenzweig, M.C. 2003. Predominant autoantibody production by early human B cell precursors. Science 301:1374–1377PubMedGoogle Scholar
  129. Watts, C. 2001. Antigen processing in the endocytic compartment. Curr. Opin. Immunol. 13:26–31PubMedGoogle Scholar
  130. Weaver, C.T., Harrington, L.E., Mangan, P.R., Gavrieli, M., and Murphy, K.M. 2006. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24:677–688PubMedGoogle Scholar
  131. Wick, M.J. and Ljunggren, H.G. 1999. Processing of bacterial antigens for peptide presentation on MHC class I molecules. Immunol. Rev. 172:153–162PubMedGoogle Scholar
  132. Yewdell, J.W., Norbury, C.C., and Bennink, J.R. 1999. Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines. Adv. Immunol. 73:1–77PubMedGoogle Scholar
  133. Zerrahn, J., Held, W., and Raulet, D.H. 1997. The MHC reactivity of the T cell repertoire prior to positive and negative selection. Cell 88:627–636PubMedGoogle Scholar
  134. Zinkernagel, R.M. 2000. What is missing in immunology to understand immunity? Nat. Immunol. 1:181–185PubMedGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2008

Authors and Affiliations

  • Camilla Foged
  • Anne Sundblad

There are no affiliations available

Personalised recommendations